Gyre Therapeutics, Inc. SEC filings GYRE
Gyre Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Sep 10, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| S-8 | Employee stock plan registration | Aug 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Aug 1, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Aug 1, 2026 |
| EFFECT | Filing | Aug 3, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 16, 2026 | Jul 10, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
Jul 15, 2026 | May 4, 2026 |
| S-3/A | Filing | Jul 13, 2026 | — |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 10, 2026 |
| S-3 | Shelf registration | Jun 23, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 3 | Initial insider ownership | May 7, 2026 | May 4, 2026 |
| 3 | Initial insider ownership | May 7, 2026 | May 4, 2026 |
| 3 | Initial insider ownership | May 7, 2026 | May 4, 2026 |
| 3 | Initial insider ownership | May 7, 2026 | May 4, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 6, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 6, 2026 | — |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| DEFA14A | Additional proxy material | May 4, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2026 |
| 8-K/A |
Amended current report
Material agreement
|
Apr 17, 2026 | Mar 2, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Mar 23, 2026 | Mar 22, 2026 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 144 | Notice of proposed sale | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 18, 2025 |
| 3 | Initial insider ownership | Aug 26, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 22, 2025 | Aug 18, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 11, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 7, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 8-K |
Current report
Material agreement
|
May 23, 2025 | May 22, 2025 |
| 424B5 | Prospectus supplement | May 23, 2025 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 14, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Apr 25, 2025 | Mar 24, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Apr 18, 2025 | Apr 16, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 19, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 27, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 21, 2025 | Jan 16, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 14, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4/A | Form 4/a | Jan 10, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 5, 2025 |
| 3 | Initial insider ownership | Jan 7, 2025 | Jan 5, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 6, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 30, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 30, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 27, 2024 | Nov 27, 2024 |
| 424B5 | Prospectus supplement | Nov 27, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| S-3 | Shelf registration | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| SC 13D | Ownership over 5% (active) | Sep 6, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 6, 2024 | — |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 3 | Initial insider ownership | Aug 8, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 8, 2024 | Aug 6, 2024 |
| 144 | Notice of proposed sale | Jul 18, 2024 | — |
| 144 | Notice of proposed sale | Jul 17, 2024 | — |
| 144 | Notice of proposed sale | Jul 16, 2024 | — |
| 144 | Notice of proposed sale | Jul 15, 2024 | — |
| RW | Filing | Jul 12, 2024 | — |
| RW | Filing | Jul 12, 2024 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jul 5, 2024 | Jun 28, 2024 |
| 144 | Notice of proposed sale | Jul 3, 2024 | — |
| 144 | Notice of proposed sale | Jul 2, 2024 | — |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 144 | Notice of proposed sale | Jul 1, 2024 | — |
| 144 | Notice of proposed sale | Jun 28, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2024 | Jun 12, 2024 |
| S-3 | Shelf registration | May 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 30, 2024 | May 30, 2024 |
| S-3 | Shelf registration | May 30, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 8, 2024 | May 7, 2024 |
| 4 | Insider transaction | May 2, 2024 | May 1, 2024 |
| 144 | Notice of proposed sale | May 1, 2024 | — |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 12, 2024 |
| 144 | Notice of proposed sale | Apr 9, 2024 | — |
| 144 | Notice of proposed sale | Apr 8, 2024 | — |
| 144 | Notice of proposed sale | Apr 5, 2024 | — |
| 144 | Notice of proposed sale | Apr 4, 2024 | — |
| 144 | Notice of proposed sale | Apr 3, 2024 | — |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 144 | Notice of proposed sale | Apr 2, 2024 | — |
| 144 | Notice of proposed sale | Apr 1, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GYRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC. (until Oct 27, 2023); TARGACEPT INC (until Aug 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.